The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The stock up 5% to Rs 264 after the company said that the board will meet on Nov 16, to consider the issue of bonus shares.
Thus far in 2016, the stock outperformed the market by surging 102%, as compared to 5% rise in Sensex.
The stock was up 2.4% at Rs 285 on BSE, as compared to 0.09% rise in the S&P BSE Sensex at 10.10 am.
The stock listed at Rs 430 on the National Stock Exchange , a 3.4% below its issue price of Rs 445 per share.
The stock surged 13% to Rs 86.35 on BSE in intra-day trade.
The stock moved higher by 12% to Rs 902 on BSE on back of heavy volumes.
Markets continued to trade firm led by index heavyweights ITC and ICICI Bank
The stock dipped 6.5% to Rs 1,536 on BSE in intra-day trade.
The stock was up 3% to Rs 257 on BSE in intra-day trade, extending its 5% gain in past two trading sessions.
OCL India hits a record high of Rs 997, up 7% and Dalmia Bharat was up 2.6% at Rs 2,043 on BSE in early morning trade.
PNB Housing Finance listed at 11% premium to issue price of Rs 775 on the BSE
The stock rallied 20% to Rs 840 on BSE after the company reported profit of Rs 31 crore in Q2FY17 against Rs 7 crore in Q2FY16.
The stock hit an intra-day high of Rs 903, after listing at Rs 863, an 11% premium over its issue price of Rs 775 per share.
The stock was up 6% at Rs 1,509 on BSE, as compared to 0.8% rise in the S&P BSE Sensex att 09:26 am.
Sun Pharma, Dr Reddy's, Jubilant Life, Strides Shasun, Aurobindo Pharma were down 5% each over possible US probe into cartelisation
The stock soared 20% to Rs 37.40 in intra-day trade, up 44% in past two trading days from Rs 26 on Nov 2.
The stock dipped 6% to Rs 208 in intra-day trade, extending its yesterday's 17% fall on BSE.
The BSE Mid-Cap index was currently off 1%. The BSE Small-Cap index was currently off 1.94%
Pharma shares were among the top losers with Sun Pharma declining the most
Post Q2FY17 results, in past six trading sessions the stock fallen 10% against 2% fall in S&P BSE Sensex.